Research focuses on how osteosarcoma reaches the lungs and what may prevent it
A research team at Oregon Health and Science University (OHSU) has been awarded $3.17 million from the National Institutes of Health to develop new laboratory models designed to better understand how osteosarcoma spreads to the lungs.
The work focuses on how osteosarcoma moves from bone to lung, and what may prevent it from establishing there. It forms part of a wider $9.2 million investment into the Knight Cancer Precision Biofabrication Hub, aimed at improving how cancers that grow in or spread to bone are studied.
Why this matters
For many patients, the lungs are the most common site of spread. Once osteosarcoma reaches the lungs, treatment becomes more difficult and outcomes are harder to change.
Progress in this area has been limited for decades. One of the challenges is that existing research models do not fully reflect what happens in the human body during metastasis.
Understanding this process in more detail is an essential step toward identifying more effective treatments.
A different way to study the disease
The research uses what are known as organs on chips. These are small devices that contain living human cells arranged to behave like real tissue, such as bone and lung.
These models allow researchers to observe how cancer cells interact with human tissue in real time. They aim to recreate the complex environment where cancer grows and spreads, which is difficult to capture using traditional laboratory methods.
By modelling bone and lung together, researchers can study how osteosarcoma cells move, survive, and establish themselves in a new environment.
Focus on how cancer cells survive
The project will focus on mechanisms that help cancer cells survive as they spread, particularly when they reach the lung.
Earlier work linked to this research has shown that targeting survival pathways may reduce the ability of osteosarcoma cells to grow in the lungs. The new models are designed to build on this by allowing more detailed testing of potential treatment approaches and combinations.
These models will allow researchers to:
-
Observe how osteosarcoma cells move from bone to lung
-
Study how they interact with surrounding tissue
-
Test potential treatments in a more realistic setting
-
Assess safety before moving toward clinical trials
Where this fits
This work is part of a broader shift toward building models that better reflect human biology. The bone environment plays an active role in how cancer develops and spreads, and understanding this interaction is key to making progress.
By improving how osteosarcoma is studied, researchers aim to identify approaches that are more likely to translate into effective treatments.
What this means
This is early-stage research. It will take time before findings like this lead to changes in treatment.
However, improving how osteosarcoma is studied is an important step. Better models can help identify which approaches should move forward into clinical trials and which are less likely to benefit patients.
Clinical trials remain an important route to accessing new and emerging treatment options. Research like this helps build the evidence needed to support those next steps.
If you are exploring clinical trials, the Osteosarcoma Now Clinical Trial Explorer is designed to provide clear and up to date information to support that process.